PL1466599T3 - Stężone roztwory oksaliplatyny - Google Patents

Stężone roztwory oksaliplatyny

Info

Publication number: PL1466599T3
Authority: PL; Poland
Prior art keywords: oxaliplatinum; concentrated solution; oxaliplatin; pharmaceutical composition; water
Prior art date: 2003-03-28

Application number

PL04007307T

Other languages

English (en)

Inventor

Edgar Schridde

Bernd Merbach

Stefan-Peter Gimmel

Original Assignee

Stada Arzneimittel Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-28

Filing date

2004-03-26

Publication date

2008-02-29

2004-03-26 Application filed by Stada Arzneimittel Ag filed Critical Stada Arzneimittel Ag

2008-02-29 Publication of PL1466599T3 publication Critical patent/PL1466599T3/pl

Links

MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 abstract 3
DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 abstract 2
229960001756 oxaliplatin Drugs 0.000 abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
150000001450 anions Chemical class 0.000 abstract 1
239000000824 cytostatic agent Substances 0.000 abstract 1
230000001085 cytostatic effect Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
239000008103 glucose Substances 0.000 abstract 1
230000010534 mechanism of action Effects 0.000 abstract 1
235000006408 oxalic acid Nutrition 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Dermatology (AREA)
Organic Chemistry (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL04007307T 2003-03-28 2004-03-26 Stężone roztwory oksaliplatyny PL1466599T3 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10314377A DE10314377A1 (de)	2003-03-28	2003-03-28	Gebrauchsfertige Oxaliplatin-Lösungen
EP04007307A EP1466599B1 (de)	2003-03-28	2004-03-26	Oxaliplatinlösungskonzentrate

Publications (1)

Publication Number	Publication Date
PL1466599T3 true PL1466599T3 (pl)	2008-02-29

Family

ID=32864348

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL04007309T PL1466600T3 (pl)	2003-03-28	2004-03-26	Gotowe do użycia roztwory oksaliplatyny
PL04007307T PL1466599T3 (pl)	2003-03-28	2004-03-26	Stężone roztwory oksaliplatyny

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL04007309T PL1466600T3 (pl)	2003-03-28	2004-03-26	Gotowe do użycia roztwory oksaliplatyny

Country Status (6)

Country	Link
EP (3)	EP2106793A1 (pl)
AT (2)	ATE374022T1 (pl)
DE (3)	DE10314377A1 (pl)
ES (2)	ES2303611T3 (pl)
PL (2)	PL1466600T3 (pl)
SI (2)	SI1466600T1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2441445B (en) *	2003-08-28	2008-04-23	Mayne Pharma Ltd	Acid containing oxaliplatin formulation
CN101703467A (zh) *	2003-08-28	2010-05-12	梅恩医药有限公司	含有酸的奥沙利铂制剂
CZ300795B6 (cs) *	2003-09-02	2009-08-12	Pliva-Lachema A. S.	Farmaceutická kompozice a zpusob její výroby
DE102004052877B4 (de) *	2004-11-02	2008-06-19	Ebewe Pharma Ges.M.B.H. Nfg.Kg	Stabile wässrige Formulierungen eines Platin-Derivats
DE102005038347A1 (de) *	2005-08-11	2007-02-15	Hexal Ag	Herstellung einer Oxaliplatin-Lösung und Behälter sowie Behälter-Set mit der Lösung
WO2007029268A2 (en) *	2005-09-05	2007-03-15	Dabur Pharma Limited	Stable oxaliplatin formulation
CZ300664B6 (cs) *	2007-01-22	2009-07-15	Pliva-Lachema A. S.	Sterilní kapalná farmaceutická kompozice a zpusob její výroby
EP2131849B1 (en)	2007-03-02	2011-10-26	The University Of Wollongong	Compositions and methods for delivery of anti-cancer agents
US20100267824A1 (en)	2007-11-12	2010-10-21	Intas Pharmaceuticals Limited	Stable oxaliplatin composition for parenteral administration
US20110144202A1 (en) *	2008-06-16	2011-06-16	Uwe Marx	Concentrated oxaliplatin solution and its method of preparation
JP5929607B2 (ja) *	2012-08-06	2016-06-08	ニプロ株式会社	オキサリプラチン製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0897389B1 (fr) *	1996-03-11	2002-07-03	Yoshinori Kidani	Complexes de platine dinucleaires, procede pour leur preparation et compositions pharmaceutiques en contenant
GB9804013D0 (en) *	1998-02-25	1998-04-22	Sanofi Sa	Formulations
RU2252022C2 (ru) *	1999-08-30	2005-05-20	Дебиофарм С.А.	Стабильный фармацевтический препарат оксалиплатины для парентерального введения
US20040186172A1 (en) *	2001-07-02	2004-09-23	Houssam Ibrahim	Oxaliplatin active substance with a very low content of oxalic acid
US6476068B1 (en) *	2001-12-06	2002-11-05	Pharmacia Italia, S.P.A.	Platinum derivative pharmaceutical formulations

2003
- 2003-03-28 DE DE10314377A patent/DE10314377A1/de not_active Withdrawn
2004
- 2004-03-26 EP EP08004906A patent/EP2106793A1/de not_active Withdrawn
- 2004-03-26 SI SI200430750T patent/SI1466600T1/sl unknown
- 2004-03-26 AT AT04007307T patent/ATE374022T1/de active
- 2004-03-26 ES ES04007309T patent/ES2303611T3/es not_active Expired - Lifetime
- 2004-03-26 SI SI200430540T patent/SI1466599T1/sl unknown
- 2004-03-26 AT AT04007309T patent/ATE395057T1/de active
- 2004-03-26 PL PL04007309T patent/PL1466600T3/pl unknown
- 2004-03-26 PL PL04007307T patent/PL1466599T3/pl unknown
- 2004-03-26 ES ES04007307T patent/ES2290575T3/es not_active Expired - Lifetime
- 2004-03-26 DE DE502004007103T patent/DE502004007103D1/de not_active Expired - Lifetime
- 2004-03-26 EP EP04007309A patent/EP1466600B1/de not_active Expired - Lifetime
- 2004-03-26 DE DE502004005055T patent/DE502004005055D1/de not_active Expired - Lifetime
- 2004-03-26 EP EP04007307A patent/EP1466599B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
SI1466600T1 (sl)	2008-08-31
ATE395057T1 (de)	2008-05-15
EP1466599A1 (de)	2004-10-13
PL1466600T3 (pl)	2008-10-31
DE502004005055D1 (de)	2007-11-08
SI1466599T1 (sl)	2008-02-29
ES2290575T3 (es)	2008-02-16
ES2303611T3 (es)	2008-08-16
EP2106793A1 (de)	2009-10-07
EP1466600A1 (de)	2004-10-13
DE10314377A1 (de)	2004-10-07
EP1466600B1 (de)	2008-05-14
EP1466599B1 (de)	2007-09-26
DE502004007103D1 (de)	2008-06-26
ATE374022T1 (de)	2007-10-15

Similar Documents

Publication	Publication Date	Title
BR0108452A (pt)	2003-04-01	Inibidores da oxidação parcial de ácido graxo no tratamento de insuficiência cardìaca congestiva
GB0105772D0 (en)	2001-04-25	Use
CO5580776A2 (es)	2005-11-30	Formulacion farmaceutica estable en solucion de oxaliplatino
MY130441A (en)	2007-06-29	Solutions containing epinastin
SE0001899D0 (sv)	2000-05-22	New compounds
SI1466599T1 (sl)	2008-02-29	Koncentrirana raztopina oksaliplatina
BG106158A (en)	2002-06-28	New use of compounds as antibacterial agents
EP1413303A4 (en)	2004-10-20	PROMOTERS FOR GROWTH IN PORK AND METHOD FOR PROMOTING GROWTH IN PORK
PT1047413E (pt)	2011-10-13	Composição farmacêutica incluindo pelo menos um inibidor da aminopeptidase a
AU2001285944A1 (en)	2002-03-26	Fungicidal agent containing n-chlorotaurine and use thereof
WO2002009717A1 (en)	2002-02-07	Erectile dysfunction remedies containing prostaglandin derivatives as the active ingredient
WO2007058568A3 (en)	2007-10-04	Salts of 9-oxoacridine-10-acetic acid with 1-alkylamino-1-desoxy-polyols
MXPA01007210A (es)	2004-10-29	Agente para el tratamiento de enfermedad de parkinson que comprende un agente que mejora la funcion del astrocito como ingrediente activo.
MY144306A (en)	2011-08-29	Aquoues solution of olanexidine, method of preparing the aqueous solution, and disinfectant
AU2001282238A1 (en)	2002-02-13	Dihydroporphyrin derivatives and their uses
WO2002098843A3 (en)	2003-05-01	Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors
WO2008155920A1 (ja)	2008-12-24	肝細胞増殖促進作用を有する医薬
WO2004080188A3 (en)	2005-06-09	Methods for reducing meat discoloration
TW200505482A (en)	2005-02-16	Lklf/klf2 gene expression promoters
HUP9800078A2 (hu)	1999-09-28	Gyógyászati készítmény, amely hatóanyagként jódot és ezüstnitrátot tartalmazó etanolos oldatból áll, és eljárás előállítására
GR1004434B (el)	2004-02-03	Χρησηατουαdiclofenacαhααποδεκτωνααλατωνααυτουαγιαατηνααντιμετωπισηατωναεγκαυματων
RU2002102883A (ru)	2003-09-20	Средство для предпосевной обработки семян
MXPA02011535A (es)	2003-06-06	Medicamento para combatir la depresion respiratoria.
MY135593A (en)	2008-05-30	Dry syrup preparation of procaterol comprising ascorbic acid and citric acid
ATE474567T1 (de)	2010-08-15	Kombinationspräparate enthaltend 2- methylthiazolidin-2,4-dicarbonsäure